期刊文献+

Galectin-7和S100A9表达与宫颈鳞癌发生发展的相关性 被引量:5

Expression of galectin-7 and S100A9 and development of cervical squamous carcinoma
下载PDF
导出
摘要 目的:探讨galectin-7和S100A9表达与宫颈鳞癌发生、发展的关系。方法:采用免疫组织化学法检测243例宫颈上皮内瘤变(CIN)及宫颈鳞癌标本中galectin-7和S100A9的表达情况,结合临床病理资料,分析其与宫颈鳞癌发生、发展的关系。结果:Galectin-7和S100A9在CIN及宫颈鳞癌中表达差异有统计学意义(均P<0.05),galectin-7在正常宫颈组织、CIN I级、CIN II级、CIN III级、宫颈鳞癌中阳性表达率分别为56.7%,41.9%,32.0%,27.3%,25.0%,组间比较发现galectin-7在正常宫颈组织与宫颈鳞癌中表达差异有统计学意义(P<0.0045)。S100A9在正常宫颈组织、CIN I级、CIN II级、CIN III级、宫颈鳞癌中阳性表达率分别为80.0%,77.4%,48.0%,27.3%,20.2%,组间比较发现S100A9在正常宫颈组织与CIN III级、正常宫颈组织与宫颈鳞癌、CIN I级与CIN III级、CIN I级与宫颈鳞癌、CIN II级与宫颈鳞癌中表达差异均有统计学意义(均P<0.0045)。Galectin-7与S100A9在CIN及宫颈鳞癌中表达呈正相关,但关系较弱(rs=0.298,P<0.001)。Galectin-7和S100A9表达均与宫颈鳞癌临床分期、淋巴结转移有关(均P<0.05),而与年龄、分化程度无关(P≥0.05);galectin-7表达与宫颈鳞癌患者预后有关(P<0.05)。单因素Cox回归分析示国际妇产科联盟(FIGO)分期、淋巴结转移及galectin-7与宫颈鳞癌患者5年生存率有关,多因素Cox分析进一步验证了这一结果。结论:Galectin-7和S100A9表达与宫颈鳞癌发生、宫颈鳞癌临床分期、淋巴结转移有关,galectin-7表达可能还与宫颈鳞癌患者预后有关。宫颈鳞癌患者长期生存时间与FIGO分期、淋巴结转移及galectin-7的表达有关。 Objective:To observe the correlation between the expression of galectin-7 and S100A9 with the development of cervical squamous carcinoma.Methods:Immunohistochemical SP staining was used to detect the expression of galectin-7 and S100A9 in 243 patients with cervical intraepithelial neoplasia (CIN) or cervical squamous carcinoma. The association of clinical data with galectin-7 and S100A9 expression was examined. Results:The expression of galectin-7 and S100A9 in CIN and cervical squamous carcinoma was signiifcantly different (P〈0.05). The positive rates of galectin-7 in normal cervical tissues, CIN I, CIN II, CIN III, and cervical squamous carcinoma were 56.7%, 41.9%, 32.0%, 27.3%, and 25.0%, repectively. Statistic analysis found significant difference between the normal cervical tissues and cervical squamous carcinoma (P〈0.0045). The positive rates of S100A9 in CIN I, CIN II, CIN III, and cervical squamous carcinoma were 80.0%, 77.4%, 48.0%, 27.3%, and 20.2%. Statistic analysis showed significant difference between the normal tissues and CIN III, the normal cervical tissues and cervical squamous carcinoma, CIN I and CIN III, CIN I and cervical squamous carcinoma, CIN II and cervical squamous carcinoma (P〈0.0045). A positive correlation was found between galectin-7 and S100A9 expression in CIN and cervical squamous carcinoma (rs=0.298, P〈0.001). Expressions of both galectin-7 and S100A9 in cervical squamous carcinoma were associated with the clinical stage and lymph nodes (P〈0.05), but not with patient's age and degree of differentiation (P〉0.05). Expression of galectin-7 was associated with the survival rate of patients with cervical squamous carcinoma (P〈0.05). Univariate analysis of Cox proportional hazards regression model revealed that the FIGO stage, lymph nodes metastasis, and the expression of galectin-7 were relevant to the 5 year survival rate of patients with cervical squamous carcinoma, which was comifrmed by multiple analysis of Cox proportional hazards regression model. Conclusion:Expression of galectin-7 and S100A9 is related with cervical the tumorigenesis of carcinoma, clinical stage, and lymph nodes of cervical squamous carcinoma. Galectin-7 is probably associated with the prognosis. The long-term survival of patients with cervical carcinoma may be associated with FIGO stage, lymph node metastasis, and the expression of galectin-7.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2013年第9期888-895,共8页 Journal of Central South University :Medical Science
基金 国家自然科学基金(81172470) 湖南省自然科学基金(11JJ5080) 湖南省科技计划项目(2012SK3195)~~
关键词 galectin-7 S100A9 宫颈鳞癌 发展 预后 galectin-7 S100A9 cervical squamous carcinoma development prognosis
  • 相关文献

参考文献17

  • 1Kuwabara I, Kuwabara Y, Yang RY, et al.Galectin-7(PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release [J].J Biol Chem, 2002, 277(5): 3487-3497.
  • 2Li CS, Chen HY, Ding F, et al.A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway [J].Biochem J, 2009, 422(2): 363-372.
  • 3Inagaki Y, Higashi K, Kushida M, et al.Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7[J].Gastroenterology, 2008, 134(4): 1180-1190.
  • 4Zhu H, Pei H P, Zeng S, et al.Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma [J].J Proteome Res, 2009, 8(8): 3969-3976.
  • 5Shadeo A, Chari R, Vatcher G, et al.Comprehensive serial analysis of gene expression of the cervical transcriptome [J].BMC Genomics,2007, 8: 142.
  • 6Bernerd F, Sarasin A, Magnaldo T.Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes [J].Proc Natl Acad Sci USA, 1999, 96(20): 11329-11334.
  • 7Ueda S, Kuwabara I, Liu FT.Suppression of tumor growth by galectin-7 gene transfer [J].Cancer Res, 2004, 64(16): 5672-5676.
  • 8Kopitz J, Andre S, von Reitzenstein C, et al.Homodimeric galectin-7(P53-induced gene 1) is a negative growth regulator for human neuroblastoma cells [J].Oncogene, 2003, 22( 40): 6277-6288.
  • 9Li C, Chen H, Ding F, et al.A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway[J].Biochem J, 2009, 422(2): 363-372.
  • 10Luo AP, Kong JP, Hu GX, et al.Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray [J].Oncogene, 2004, 23(6): 1291-1299.

同被引文献46

  • 1孙瑞芳,赵富玺,王晋芬,陈向伟.宫颈鳞状细胞癌及宫颈上皮内瘤样变组织中HPV16感染与P21^(waf)、Ki67表达的关系及意义[J].现代预防医学,2005,32(10):1284-1286. 被引量:2
  • 2任占平,石,陈蔚麟,唐德艳.宫颈癌组织中HPV16、18E6蛋白表达的观察[J].中华病理学杂志,1997,26(3):161-162. 被引量:18
  • 3Saussez S, Kiss R. Galectin 7[J]. Cell Mol I.ife Sci. 2006,63(6) :686-697.
  • 4Ueda S, Kuwabara I, Fu L. Suppression of tumor growth by galectin-7 gene transfer[J]. Cancer Res, 2004,64(16) :5672-5676.
  • 5Demers M,Biron-Pain K,HO.bert J ,et al. Galectin 7 in lymphoma: elevated expression in human lymphoid malignancies and decreased ]ymphoma dissemination by antisense strategies in experimental model [J]. Cancer Res, 2007,67 (6) : 2824-2829.
  • 6Demers M ,Couillard J ,Giglia-Mari G,et al. lncreased galectin-7 gene expression in lymphoma cells is under the control of I)NA methylation[J]. Biochem Biophys Res Commun,2009,387(3) :425 429.
  • 7Kim SJ.Hwang JA,Ro JY,et al. Galectin 7 is epigc netieal[y regulated tunmr suppressor in gastric cancer [J],Oncotarget.2013,4(9):1461 1471.
  • 8Cai J, Ma H, Huang F, et al. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer[J]. Int J Clin Exp Pathol, 2014,7 (8) : 4959- 4970.
  • 9Demers M, Magnaldo T, St-Pierre Y. A novel function for galectin-7:promoting tumorigenesis by up-regula- ting MMP-9 gene expression[J]. Cancer Res, 2005,65 (12) .. 5205-5210.
  • 10Kopitz J, Andr6 S, von Reitzenstein C, et al. Ho- modimeric galectin-7(p53-induced gene 1) is a neg- ative growth regulator for human neuroblastoma cells[J]. Oncogene, 2003,22 (40) .. 6277-6288.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部